OMRF researchers uncover a genetic link between lymphatic valve formation and Crohn's disease, paving the way for future treatments.

Physicians treating patients with Crohn's disease face a plethora of drug choices. Yet, overall rates of clinical response seem stable over time,1 suggesting the existence of a therapeutic ceiling ...

About 3.1 million adults in the United States have inflammatory bowel disease (IBD), which includes Crohn’s disease and ulcerative colitis (UC). But just as each person is unique, so is their ...

Bhat: From a medication standpoint, there is still much to uncover regarding why treatments vary in effectiveness among ...

In a European study, higher consumption of fruits, vegetables, legumes, and potatoes was associated with a reduced risk of ...

1 Introduction The incidence of pediatric Crohn’s disease (CD) has increased rapidly over the past decades (Kuenzig et al., 2022). During this same period, anti-tumor necrosis factor (TNF) has become ...

Introduction Adalimumab is effective for maintenance of remission in patients with Crohn’s disease (CD) at a dose of 40 mg subcutaneously every 2 weeks. However, adalimumab is associated with ...

Background/Aim: Immunosuppressants are now used much earlier in the course of Crohn’s disease; however their effect on the natural history of the disease, especially on the need for surgery, is not ...

1. Vitamin supplements Crohn’s disease can affect the body’s ability to absorb nutrients. Taking supplements can help relieve several Crohn’s-related vitamin and mineral deficiencies.

Unexpected Signs of a Crohn’s Disease Flare Approximately 40 percent of people with an inflammatory bowel disease (IBD), including Crohn’s and ulcerative colitis, experience extraintestinal ...

Legalisation of medical and recreational cannabis commerce is spreading around the world, associated with increased use1 and falling perception of the risk.2 Frequent cannabis use has increased in ...

Aims and methods To assess the impact of FOS in patients with active Crohn's disease using an adequately powered randomised double-blind placebo-controlled trial with predefined clinical, ...